Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
214.82
-0.68 (-0.32%)
At close: Apr 30, 2024, 4:00 PM
218.40
+3.58 (1.67%)
After-hours: Apr 30, 2024, 7:12 PM EDT
Biogen Employees
Biogen had 7,570 employees on December 31, 2023. The number of employees decreased by 1,155 or -13.24% compared to the previous year.
Employees
7,570
Change (1Y)
-1,155
Growth (1Y)
-13.24%
Revenue / Employee
$1,276,499
Profits / Employee
$154,108
Market Cap
31.28B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7,570 | -1,155 | -13.24% |
Dec 31, 2022 | 8,725 | -885 | -9.21% |
Dec 31, 2021 | 9,610 | 510 | 5.60% |
Dec 31, 2020 | 9,100 | 1,700 | 22.97% |
Dec 31, 2019 | 7,400 | -400 | -5.13% |
Dec 31, 2018 | 7,800 | 500 | 6.85% |
Dec 31, 2017 | 7,300 | -100 | -1.35% |
Dec 31, 2016 | 7,400 | 50 | 0.68% |
Dec 31, 2015 | 7,350 | -200 | -2.65% |
Dec 31, 2014 | 7,550 | 700 | 10.22% |
Dec 31, 2013 | 6,850 | 900 | 15.13% |
Dec 31, 2012 | 5,950 | 950 | 19.00% |
Dec 31, 2011 | 5,000 | 150 | 3.09% |
Dec 31, 2010 | 4,850 | 100 | 2.11% |
Dec 31, 2009 | 4,750 | 50 | 1.06% |
Dec 31, 2008 | 4,700 | 400 | 9.30% |
Dec 31, 2007 | 4,300 | 550 | 14.67% |
Dec 31, 2006 | 3,750 | 410 | 12.28% |
Dec 31, 2005 | 3,340 | -926 | -21.71% |
Dec 31, 2004 | 4,266 | 539 | 14.46% |
Feb 20, 2004 | 3,727 | 2,732 | 274.57% |
Jan 31, 2003 | 995 | 303 | 43.79% |
Jan 31, 2002 | 692 | 199 | 40.37% |
Jan 31, 2001 | 493 | 86 | 21.13% |
Jan 31, 2000 | 407 | 42 | 11.51% |
Jan 31, 1999 | 365 | 26 | 7.67% |
Dec 31, 1997 | 339 | 71 | 26.49% |
Dec 31, 1996 | 268 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Humana | 67,600 |
Cardinal Health | 48,000 |
ICON PLC | 41,100 |
Haleon | 25,408 |
Alcon | 25,315 |
Zimmer Biomet Holdings | 18,000 |
Mettler-Toledo International | 17,300 |
West Pharmaceutical Services | 10,600 |
BIIB News
- 5 days ago - Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA® - GlobeNewsWire
- 6 days ago - Biogen Stock Rises After Earnings and on Jump in Alzheimer's Drug Sales - Barrons
- 6 days ago - Biogen Q1 2024 results surpass expectation despite revenue decline - Invezz
- 6 days ago - Biogen first-quarter profit tops estimates as Alzheimer's drug uptake improves - Market Watch
- 6 days ago - Biogen beats quarterly profit estimates, Alzheimer's drug sales jump - Reuters
- 6 days ago - Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up - CNBC
- 5 weeks ago - Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease - Business Wire
- 5 weeks ago - EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes - Reuters